"Efficacy of Treatment Regimens for Sodium-Glucose Counter Transporter 2 Inhibitor (Emaglyf) with Metformin and DPP-4 Inhibitor (Januvia) in Patients with Type 2 Diabetes Mellitus with Stage 1-3 Chronic Kidney Disease"
Teshabekova Mohira KudratovnaResident Physician at the Department of Diabetic Nephropathy, RSNPMTSE named by acad Y.Kh. Turakulov, Republic of Uzbekistan
2022en
Ochiq kirishOlmos
Litsenziya: cc-by
ABI
Annotatsiya
Efficacy of Treatment Regimens for Sodium-Glucose Counter Transporter 2 Inhibitor (Emaglyf) with Metformin and DPP-4 Inhibitor (Januvia) in Patients with Type 2 Diabetes Mellitus with Stage 1-3 Chronic Kidney Disease.Biomed
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos6 ta foydalanilgan manba